Enhanced radio sensitivity with iodinated contrast agents using monochromatic synchrotron X-rays on human cancerous cells.
Estève
F
F
Equipe d'Accueil RSRM, Unité IRM CHU, Grenoble, France.
Corde
S
S
Elleaume
H
H
Adam
J F
JF
Joubert
A
A
Charvet
A M
AM
Biston
M C
MC
Balosso
J
J
Le Bas
J F
JF
D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D003287:Contrast Media / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007479:Iopamidol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D007485:Ioxaglic Acid / Q000494:pharmacology*; D007822:Laryngeal Neoplasms / Q000532:radiotherapy*; D017785:Photons; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D017356:Synchrotrons; D014057:Tomography, X-Ray Computed; D014407:Tumor Cells, Cultured / Q000528:radiation effects
D003287:Contrast Media; D011838:Radiation-Sensitizing Agents; C057937:iomeprol; D007479:Iopamidol; D007485:Ioxaglic Acid